194 related articles for article (PubMed ID: 34952244)
61. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
62. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
63. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles.
Kim TH; Mount CW; Gombotz WR; Pun SH
Biomaterials; 2010 Oct; 31(28):7386-97. PubMed ID: 20598741
[TBL] [Abstract][Full Text] [Related]
64. Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery.
Leong J; Chin W; Ke X; Gao S; Kong H; Hedrick JL; Yang YY
Nanomedicine; 2018 Nov; 14(8):2666-2677. PubMed ID: 30017961
[TBL] [Abstract][Full Text] [Related]
65. Dual-Responsive Doxorubicin-Conjugated Polymeric Micelles with Aggregation-Induced Emission Active Bioimaging and Charge Conversion for Cancer Therapy.
Su X; Ma B; Hu J; Yu T; Zhuang W; Yang L; Li G; Wang Y
Bioconjug Chem; 2018 Dec; 29(12):4050-4061. PubMed ID: 30404436
[TBL] [Abstract][Full Text] [Related]
66. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
[TBL] [Abstract][Full Text] [Related]
67. Exogenous vitamin C triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency.
Zhu Y; He Y; Su T; Li C; Cai S; Wu Z; Huang D; Zhang X; Cao J; He B
J Mater Chem B; 2020 Jun; 8(23):5109-5116. PubMed ID: 32412025
[TBL] [Abstract][Full Text] [Related]
68. ROS-Activated Ratiometric Fluorescent Polymeric Nanoparticles for Self-Reporting Drug Delivery.
Zhang M; Song CC; Su S; Du FS; Li ZC
ACS Appl Mater Interfaces; 2018 Mar; 10(9):7798-7810. PubMed ID: 29424527
[TBL] [Abstract][Full Text] [Related]
69. Near-Infrared Light-Triggered Drug Release from Ultraviolet- and Redox-Responsive Polymersome Encapsulated with Core-Shell Upconversion Nanoparticles for Cancer Therapy.
Tsai MF; Lo YL; Soorni Y; Su CH; Sivasoorian SS; Yang JY; Wang LF
ACS Appl Bio Mater; 2021 Apr; 4(4):3264-3275. PubMed ID: 35014413
[TBL] [Abstract][Full Text] [Related]
70. Chitosan-based DDSs for pH/hypoxia dual-triggered DOX delivery: Facile morphology modulation for higher in vitro cytotoxicity.
Xie P; Liu P
Carbohydr Polym; 2022 Jan; 275():118760. PubMed ID: 34742449
[TBL] [Abstract][Full Text] [Related]
71. 2,2'-Dithiodisuccinic acid-stabilized polyion complex micelles for pH and reduction dual-responsive drug delivery.
Du Y; Yan W; Lian H; Xiang C; Duan L; Xiao C
J Colloid Interface Sci; 2018 Jul; 522():74-81. PubMed ID: 29579564
[TBL] [Abstract][Full Text] [Related]
72. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
73. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
[TBL] [Abstract][Full Text] [Related]
74. Synthesis of amphiphilic copolymers containing zwitterionic sulfobetaine as pH and redox responsive drug carriers.
Cai M; Leng M; Lu A; He L; Xie X; Huang L; Ma Y; Cao J; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2015 Feb; 126():1-9. PubMed ID: 25531063
[TBL] [Abstract][Full Text] [Related]
75. pH-responsive charge-reversal polymer-functionalized boron nitride nanospheres for intracellular doxorubicin delivery.
Feng S; Zhang H; Zhi C; Gao XD; Nakanishi H
Int J Nanomedicine; 2018; 13():641-652. PubMed ID: 29440891
[TBL] [Abstract][Full Text] [Related]
76. Phenylboronic ester-modified anionic micelles for ROS-stimuli response in HeLa cell.
Wang QY; Xu YS; Zhang NX; Dong ZP; Zhao BN; Liu LC; Lu T; Wang Y
Drug Deliv; 2020 Dec; 27(1):681-690. PubMed ID: 32393138
[TBL] [Abstract][Full Text] [Related]
77. In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy.
Shao Y; Luo W; Guo Q; Li X; Zhang Q; Li J
Drug Des Devel Ther; 2019; 13():2043-2055. PubMed ID: 31388296
[No Abstract] [Full Text] [Related]
78. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
[TBL] [Abstract][Full Text] [Related]
79. Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake.
Dong F; Dong X; Zhou L; Xiao H; Ho PY; Wong MS; Wang Y
Colloids Surf B Biointerfaces; 2016 Apr; 140():324-331. PubMed ID: 26764113
[TBL] [Abstract][Full Text] [Related]
80. Intracellular Doxorubicin Delivery of a Core Cross-linked, Redox-responsive Polymeric Micelles.
Lili Y; Ruihua M; Li L; Fei L; Lin Y; Li S
Int J Pharm; 2016 Feb; 498(1-2):195-204. PubMed ID: 26706436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
